|
UK’s NICE Reverses Draft Decision, Recommends Pharmaxis’ Bronchitol
The UK’s National Institute for Health and Clinical Excellence (NICE) has recommended Pharmaxis’ Bronchitol as a cost-effective treatment for some adults with cystic fibrosis (CF).
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives